Cargando…

Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation

The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Honglin, Monack, Denise M., Kayagaki, Nobuhiko, Wertz, Ingrid, Yin, Jianpin, Wolf, Beni, Dixit, Vishva M.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212976/
https://www.ncbi.nlm.nih.gov/pubmed/16301742
http://dx.doi.org/10.1084/jem.20051194
_version_ 1782148799339167744
author Zhou, Honglin
Monack, Denise M.
Kayagaki, Nobuhiko
Wertz, Ingrid
Yin, Jianpin
Wolf, Beni
Dixit, Vishva M.
author_facet Zhou, Honglin
Monack, Denise M.
Kayagaki, Nobuhiko
Wertz, Ingrid
Yin, Jianpin
Wolf, Beni
Dixit, Vishva M.
author_sort Zhou, Honglin
collection PubMed
description The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor κB (NF-κB) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and IκBα. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-κB signaling by selectively removing K63-linked polyubiquitin chains that activate IκB kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of IκBα. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63-linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ.
format Text
id pubmed-2212976
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22129762008-03-11 Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation Zhou, Honglin Monack, Denise M. Kayagaki, Nobuhiko Wertz, Ingrid Yin, Jianpin Wolf, Beni Dixit, Vishva M. J Exp Med Brief Definitive Report The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor κB (NF-κB) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and IκBα. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-κB signaling by selectively removing K63-linked polyubiquitin chains that activate IκB kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of IκBα. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63-linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ. The Rockefeller University Press 2005-11-21 /pmc/articles/PMC2212976/ /pubmed/16301742 http://dx.doi.org/10.1084/jem.20051194 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Zhou, Honglin
Monack, Denise M.
Kayagaki, Nobuhiko
Wertz, Ingrid
Yin, Jianpin
Wolf, Beni
Dixit, Vishva M.
Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
title Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
title_full Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
title_fullStr Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
title_full_unstemmed Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
title_short Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation
title_sort yersinia virulence factor yopj acts as a deubiquitinase to inhibit nf-κb activation
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212976/
https://www.ncbi.nlm.nih.gov/pubmed/16301742
http://dx.doi.org/10.1084/jem.20051194
work_keys_str_mv AT zhouhonglin yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation
AT monackdenisem yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation
AT kayagakinobuhiko yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation
AT wertzingrid yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation
AT yinjianpin yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation
AT wolfbeni yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation
AT dixitvishvam yersiniavirulencefactoryopjactsasadeubiquitinasetoinhibitnfkbactivation